The United States may receive an additional 300 million doses of the Coronavirus vaccine by the end of July, which raises storage concerns

The new estimates, which are included in the paper along with the recommendations, come as the Biden administration faces increasing pressure to facilitate a fair distribution of vaccines around the world, and on Wednesday, Oxfam issued an open letter signed by more than 100 award-winning former heads of state. Noble invites to invite. President Biden waives intellectual property rules for coronavirus vaccines and “places the collective right to safety for all before the commercial monopolies of the few.” The story below continues the announcement that “leadership from the United States regarding safe, effective and equitable global access to a Covid-19 vaccine is imperative,” argues the Duke paper, prompting Washington to increase funding for vaccine-sharing programs, but further afield to donate overdoses and use its influence to open up the industry. The vaccine. Another suggestion, made in a letter with support from the Center for Strategic and International Studies (CSIS), calls for the United States to donate 10 percent of its overdoses over the summer, and move to 50 percent by the end of the year, and argues that Biden should deliver a speech that Spring to present the issue to the American people. The proposals come amid new evidence that the US vaccination campaign is working, even as the virus spreads uncontrollably in many parts of the world, and the most virulent variants continue to take hold. The story continues without advertising under Biden, the United States re-engaging with Covax, a UN-backed initiative to help low-income countries get their vaccine doses. Secretary of State Anthony Blinken is hosting an event to support the effort on Thursday, but many experts argue that the current measures are not enough. The United States will likely have “at least 300 million or more overdoses” by the end of July, the authors of the Duke paper estimate, even as vaccination programs expand to the vast majority of children in the United States, the estimate is based on the assumption that the vaccine developed by AstraZeneca It receives emergency use The license and the Johnson & Johnson vaccine are widely used, despite rare side effects. CDC Director Rochelle Walski on April 14 detailing why there was a call to stop using the Johnson & Johnson vaccine. (The Washington Post) The oversupply in the United States is in stark contrast to the situation in many poor parts of the world, where vaccination programs were slow to start amid problems in supply and distribution, and the epidemic could eventually be prolonged and hindered its spread. US recovery … The story is still underway – the administration has pledged to donate doses. “If we had a surplus, we would share it with the rest of the world,” Biden said last month when pressed on the issue. “We’ll start making sure to take care of the Americans first, but then we’ll try to help the rest of the world.” Blinken made it clear that protecting Americans requires international action. He said in a press conference on April 5: “This epidemic will not end at home until it ends all over the world.” However, a global plan for donating doses has not been defined, and the world’s poorest 92 countries will not be able to reach a vaccination rate of 60 percent of their population until 2023 “or later” if current distribution trends continue, according to estimates by the Duke newspaper, and among the authors are former US officials such as Mark McClellan, a former commissioner of the US Food and Drug Administration under President George W. Bush. And Krishna Udayakumar, Founding Director of the Duke Global Center for Health Innovation. The story continues without announcing their recommendations reflecting the concerns of other public health experts around the world, including WHO Director-General Tedros Adhanom Ghebreyesus, who has called for vaccine distribution plans that focus only on local issues. [that] French President Emmanuel Macron in February pushed the United States and Europe to donate up to 5% of guaranteed vaccine doses, although the idea did not gain much traction. Refusing to support Kovacs, Biden reversed course and pledged $ 4 billion to support the scheme in February, and the story continues without announcing even if Kovacs were fully funded this year, he would be able to vaccinate only a quarter of the population in 92 poor countries of the world. Although many experts believe the United States needs to do more to ensure the developing world can vaccinate faster, they disagree on the approach, while the message led by Oxfam called for the United States to support a temporary waiver of ownership rules. Intellectual for the World Trade Organization, breaking vaccine monopolies, Duke experts have argued that such a measure is unnecessary and could prove that instead, they are suggesting that the United States should support the use of cooperative licensing arrangements to increase manufacturing capacity, so that production can be increased rapidly but safely. Restricting donations to overdoses, the Biden administration could amend its contracts and could provide “loans” for currently available vaccine doses (as it has already done with Mexico and Canada). It could also change the timing of delivery of vaccines so that countries most in need receive their doses first. Both the Duke proposal and CSIS indicated that while the AstraZeneca vaccine has not yet received approval for emergency use in the United States, it could be used in other countries. The United States has purchased 300 million doses of the AstraZeneca vaccine alone.